Point72 Asset Management, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol
CTMX
Shares outstanding
158,522,020 shares
Disclosed Ownership
8,084,623 shares
Ownership
5.1%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 17:30:37 UTC
Date of event
30 Jun 2025
Previous filing
14 May 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 5.1% ownership in CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX) on 30 Jun 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G/A for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX).
  • Disclosed ownership: 5.1%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 14 May 2025.
  • Current filing was accepted on 14 Aug 2025, 17:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 5.1% 8,084,623 0 8,084,623 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 5.1% 8,084,623 0 8,084,623 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 5.1% 8,084,623 0 8,084,623 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person

Sponsored